<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.1" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Comments for Nanotechnology Notes</title>
	<link>http://blogs.edf.org/nanotechnology</link>
	<description>Our experts' views on nano news</description>
	<pubDate>Thu, 04 Dec 2008 06:29:38 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.3.1</generator>
		<item>
		<title>Comment on Nano Risk Management Training Workshops by finasteride</title>
		<link>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-174</link>
		<dc:creator>finasteride</dc:creator>
		<pubDate>Sun, 16 Nov 2008 21:12:15 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-174</guid>
		<description>&lt;a href="http://finasteride.weebly.com/" rel="nofollow"&gt;proscar uses 
 
&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p><a href="http://finasteride.weebly.com/" rel="nofollow">proscar uses </p>
<p></a></p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Sticking Point:  Nanotechnology, Lizard Feet, and Taping Grown Men to the Ceiling by vijayvrao10</title>
		<link>http://blogs.edf.org/nanotechnology/2008/08/07/sticking-point-nanotechnology-lizard-feet-and-taping-grown-men-to-the-ceiling/#comment-173</link>
		<dc:creator>vijayvrao10</dc:creator>
		<pubDate>Sun, 16 Nov 2008 09:10:23 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/08/07/sticking-point-nanotechnology-lizard-feet-and-taping-grown-men-to-the-ceiling/#comment-173</guid>
		<description>What is this Nano Technology means? and it was using in TATA nanocars?</description>
		<content:encoded><![CDATA[<p>What is this Nano Technology means? and it was using in TATA nanocars?</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Nano Risk Management Training Workshops by finaster</title>
		<link>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-172</link>
		<dc:creator>finaster</dc:creator>
		<pubDate>Thu, 13 Nov 2008 05:35:03 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-172</guid>
		<description>&lt;a href="http://proscar.wikispaces.com/" rel="nofollow"&gt;saw hair loss 
 
&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p><a href="http://proscar.wikispaces.com/" rel="nofollow">saw hair loss </p>
<p></a></p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Yes, Virginia, inhaled carbon nanotubes do cause lung granulomas by R</title>
		<link>http://blogs.edf.org/nanotechnology/2008/10/31/yes-virginia-inhaled-carbon-nanotubes-do-cause-lung-granulomas/#comment-171</link>
		<dc:creator>R</dc:creator>
		<pubDate>Tue, 04 Nov 2008 00:19:10 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/10/31/yes-virginia-inhaled-carbon-nanotubes-do-cause-lung-granulomas/#comment-171</guid>
		<description>&lt;a href="http://www.vadlo.com/Cartoons/Life_in_Research_Cartoon_1213.html" rel="nofollow"&gt;Carbon nanotech cartoon&lt;/a&gt;.</description>
		<content:encoded><![CDATA[<p><a href="http://www.vadlo.com/Cartoons/Life_in_Research_Cartoon_1213.html" rel="nofollow">Carbon nanotech cartoon</a>.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Nano Risk Management Training Workshops by dulox</title>
		<link>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-170</link>
		<dc:creator>dulox</dc:creator>
		<pubDate>Fri, 24 Oct 2008 18:27:12 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-170</guid>
		<description>&lt;a href="http://einstein.phys.uwm.edu/view_profile.php?userid=384274" rel="nofollow"&gt;structure of cymbalta 
&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p><a href="http://einstein.phys.uwm.edu/view_profile.php?userid=384274" rel="nofollow">structure of cymbalta<br />
</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Nano Risk Management Training Workshops by sumatiptan</title>
		<link>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-169</link>
		<dc:creator>sumatiptan</dc:creator>
		<pubDate>Fri, 17 Oct 2008 19:06:29 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-169</guid>
		<description>&lt;a href="http://www.xanga.com/migraine_imtrex" rel="nofollow"&gt;imitrex solubility 
&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p><a href="http://www.xanga.com/migraine_imtrex" rel="nofollow">imitrex solubility<br />
</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Nano Risk Management Training Workshops by cymbalta</title>
		<link>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-168</link>
		<dc:creator>cymbalta</dc:creator>
		<pubDate>Tue, 14 Oct 2008 16:06:21 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-168</guid>
		<description>&lt;a href="http://cymbalta.wikispaces.com/" rel="nofollow"&gt;duloxetine abuse 
&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p><a href="http://cymbalta.wikispaces.com/" rel="nofollow">duloxetine abuse<br />
</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on The Nano Risk Framework Gets Ready for Shanghai by Andrew Maynard</title>
		<link>http://blogs.edf.org/nanotechnology/2008/10/02/the-nano-risk-framework-gets-ready-for-shanghai/#comment-167</link>
		<dc:creator>Andrew Maynard</dc:creator>
		<pubDate>Fri, 10 Oct 2008 13:21:31 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/10/02/the-nano-risk-framework-gets-ready-for-shanghai/#comment-167</guid>
		<description>John,

Thanks for this - development of an ISO TR based on the ED/DuPont document is an important step toward getting broader stakeholder input and buy-in to an effective stewardship framework for engineered nanomaterials and their products.</description>
		<content:encoded><![CDATA[<p>John,</p>
<p>Thanks for this - development of an ISO TR based on the ED/DuPont document is an important step toward getting broader stakeholder input and buy-in to an effective stewardship framework for engineered nanomaterials and their products.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Bacterial Resistance to Silver  (Nano or Otherwise) by Jeffrey S Graham MD</title>
		<link>http://blogs.edf.org/nanotechnology/2008/04/29/bacterial-resistance-to-silver-nano-or-otherwise/#comment-166</link>
		<dc:creator>Jeffrey S Graham MD</dc:creator>
		<pubDate>Thu, 09 Oct 2008 12:05:40 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/04/29/bacterial-resistance-to-silver-nano-or-otherwise/#comment-166</guid>
		<description>I am a urologist and when I head about silver-coated Foley (bladder) catheters it seemed like they could only be a good idea.  The thought was to prevent colonization of an indwelling catheter with bacteria, particularly in patients who have catheters permanently.  The hope was to minimize symptomatic bladder infections that then become resistant to an increasing number of traditional antibiotics.  When I see in the references bacteria commonly seen and treated in urologic practice (E.coli, Enterobacter, Pseudomonas, and Acinetobacter)  that have documented ability to develop resistance to silver it is very concerning. To some degree it doesn't limit our treatment options which still just includes the use of traditional po or IV antibiotics, but it does raise the question of whether the additional expense for these catheters is truly of long term benefit or detriment.
Jeffrey S Graham MD</description>
		<content:encoded><![CDATA[<p>I am a urologist and when I head about silver-coated Foley (bladder) catheters it seemed like they could only be a good idea.  The thought was to prevent colonization of an indwelling catheter with bacteria, particularly in patients who have catheters permanently.  The hope was to minimize symptomatic bladder infections that then become resistant to an increasing number of traditional antibiotics.  When I see in the references bacteria commonly seen and treated in urologic practice (E.coli, Enterobacter, Pseudomonas, and Acinetobacter)  that have documented ability to develop resistance to silver it is very concerning. To some degree it doesn&#39;t limit our treatment options which still just includes the use of traditional po or IV antibiotics, but it does raise the question of whether the additional expense for these catheters is truly of long term benefit or detriment.<br />
Jeffrey S Graham MD</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Nano Risk Management Training Workshops by flagyl</title>
		<link>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-164</link>
		<dc:creator>flagyl</dc:creator>
		<pubDate>Sun, 05 Oct 2008 16:59:23 +0000</pubDate>
		<guid>http://blogs.edf.org/nanotechnology/2008/03/21/nano-risk-management-training-workshops/#comment-164</guid>
		<description>&lt;a href="http://einstein.phys.uwm.edu/view_profile.php?userid=347072" rel="nofollow"&gt;metronidazole flagyl 
&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p><a href="http://einstein.phys.uwm.edu/view_profile.php?userid=347072" rel="nofollow">metronidazole flagyl<br />
</a></p>
]]></content:encoded>
	</item>
</channel>
</rss>
